Navigation Links
Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic
Date:1/11/2008

HORSHAM, PA (January 11, 2008): Nucleonics, Inc., a privately held biotechnology company focused on the development of novel RNA interference (RNAi)-based therapeutics, announced today that the company has begun treating patients in a Phase 1 human safety study of its experimental treatment for chronic Hepatitis B virus (HBV) infection, NUC B1000.

NUC B1000 (http://www.nucleonicsinc.com/products/hepb.html) is an expressed interfering RNA (eiRNA)-based product consisting of a plasmid DNA construct designed to produce four short interfering RNA (siRNA) molecules, formulated with a proprietary cationic-lipid delivery system. Each of the four siRNAs targets a different sequence of the HBV genome, collectively leading to the potential destruction or elimination of all RNA species produced by HBV within an infected cell. The result is a potent antiviral effect designed for efficacy against all HBV genotypes, including drug resistant strains. Additionally, unlike currently available HBV therapeutics, NUCB1000 is designed to specifically reduce viral antigen load in addition to viral titer, thereby reducing the destructive effects of hepatitis and increasing the potential for resolution of viral infection.

Despite the widespread availability of multiple prophylactic vaccines against HBV, chronic HBV infection remains a public health problem around the world that can lead to such serious diseases as cirrhosis, fibrosis and liver cancer in up to one-third of patients, said Principal Investigator, Robert G. Gish, M.D, Medical Director, Liver Transplant Program and Chief, Division of Hepatology and Complex GI, California Pacific Medical Center, San Francisco. Current anti-HBV drug therapies are of limited effectiveness and are not often used in patients with mild to moderate disease due to risks of developing drug resistance. Thus there is significant need for new treatments that can improve
'/>"/>

Contact: Joan Kureczka
JKureczka@comcast.net
415-821-2413
Kureczka/Martin Associates
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Eltrombopag effective for hepatitis C patients with low blood-platelet counts
2. Possible hepatitis C vaccine
3. Who will recover spontaneously from hepatitis C virus infection
4. Clearance of hepatitis C viral infection after liver transplantation
5. New clinical trial results show how personalized medicine will alter treatment of genetic disorders
6. New clinical data shows chromium picolinate improves cognitive function
7. Study of African traditional medicine will begin world-first clinical trial
8. Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design
9. Cleveland Clinic leading clinical program to improve early-stage lung cancer detection
10. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
11. Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...mber 26, 2009) Whitehead researchers have develop... pinpoint specific genes and proteins used by path...In most human cell cultures genes are present in t...rom the mother. Gene inactivation by mutation is t...tivated, the second copy usually remains active an...
(Date:11/25/2009)...duced in the stomach, may be used to boost resista...sease, Yale School of Medicine researchers report ...rnal of Neuroscience . , Parkinson,s disease is ... area of the midbrain known as the substantia nigr...Reduced production of dopamine in late-stage Parki...
(Date:11/25/2009)...25, 2009 Soil is the linchpin of the environment,.... Despite that, many students see soil as "just di...l science educators are challenged with the task o...itical importance of soil in the environment. , ... science teachers at University of Nebraska-Lincol...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Xanodyne Expands U S Sales Force and Launches Zipsor 28TM 29 28diclofenac potassium 29 Liquid Filled Capsules 6235 1Xanodyne Expands U S Sales Force and Launches Zipsor 28TM 29 28diclofenac potassium 29 Liquid Filled Capsules 6235 2Vivakor Presents at Nutraceutical Event 61275 1Vivakor Presents at Nutraceutical Event 61275 2Vivakor Presents at Nutraceutical Event 61275 3Vivakor Presents at Nutraceutical Event 61275 4Vivakor Presents at Nutraceutical Event 61275 5Vivakor Presents at Nutraceutical Event 61275 6AMICAS PACS For Mammography at RSNA 2009 61273 1AMICAS PACS For Mammography at RSNA 2009 61273 2AMICAS PACS For Mammography at RSNA 2009 61273 3
... Children who were allergic to eggs were able to e...suming increased quantities of eggs over time, res... University of Arkansas for Medical Sciences have ... took a daily dose of egg product over the two-yea...resistance to the point where most of them could e...
... As the world,s first explorers branched away from...years ago, distinct mutations accumulated in the D...etic trail for modern researchers to follow. , Rec...s classic genetic system to study ancient migratio...ople or animals as they existed tens of thousands ...
... Walking is a popular form of exercise, but may no...its, a University of Alberta study shows. , "Gener... is not likely going to give anybody marked health...levate the intensity," said Dr. Vicki Harber, lead...nted recently at the American College of Sports Me...
Other Biology News:Pilot study successful in taming allergic reactions to food 2Pilot study successful in taming allergic reactions to food 3History-hunting geneticists can still follow familiar trail 2History-hunting geneticists can still follow familiar trail 3Walking not enough for significant exercise benefits 2
(Date:11/25/2009)...eak at Economic Club of Canada , ...-- Ambassador to Speak at Economic Club of Canada.... International Investment, and Chairman and CEO of...of David Appia go to www.investinfrance.org . , ...th press to discuss recent pro-business initiative...
(Date:11/25/2009)...RNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a ...ced today that it executed,a joint venture (JV) ag...nology Co., Ltd. (Sinovac Dalian). The JV will res...e vaccines. Sinovac will contribute its expertise,...orld-class vaccines; the,other party will bring it...
(Date:11/24/2009)... , Whether it,s CD packaging, containers or i...entification) are increasingly finding their way i...objects or goods and identify them automatically b...d and process the data contained in the label. Sma... conditions of up to 100 degrees Celsius. But at h...
(Date:11/24/2009)...estment bank KTA Capital,s client Neuren Pharmaceu...ertible note private placement with a U.S. institu...d by KTA Capital as Neuren,s exclusive placement a...ork (PRWEB) November 23, 2009 -- The independent N...A Capital") has announced that its client Neu...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...a, Sept. 19 /Xinhua-PRNewswire-FirstCall/ -- China... "the Company") (Nasdaq: CSKI ), a,leading fully ...he-counter,drugs in the People,s Republic of China... completed the first phase of examinations for the...ark, which indicates that,a company,s products hav...
...ustria, September 19 Thirty seven medical,experts...n the medical,community to take urgent action to o...vere mental illness such as schizophrenia or bipol...ker, principal author of Comorbid,Somatic Illnesse...al,Policy, and Research Challenges which was publi...
...Minn., Sept. 18 MedNet Solutions, a global,eClini...udy management,systems, today announced the compan...hibitor at the 2008 Society of Clinical Data Manag... September 21 through,Wednesday, September 24 in D...ratt, PhD, Chief Marketing Officer,and Principal S...
Other Biology Technology:China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification 2China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification 3Global Psychiatrists Unite to Improve Services in Mental Health 2Global Psychiatrists Unite to Improve Services in Mental Health 3MedNet Solutions to Speak, Sponsor and Exhibit at the 2008 Society of Clinical Data Management Annual Conference in Dallas 2
...taneous dual parameter assay for mitochondrial mem...y. Active caspases are detected by carboxyfluoresc...e inhibitors, which are cell-permeable, non-cytoto...hin the cells. At the same time the mitochondrial ...
...L-4 cells were cultured in DMEM and harvested at t...gens in their native forms, cells were fixed in ac...l (5 mm) adhesive coated slide, with each wells su...achment and to minimize background staining. Each...
...yControl™ vector can be induced prior to DNA p...rovide the stability of single-copy BACs with the ...ng vectors. The kits provide the linearized vector...t size screening system) necessary to create a 10X...
...yControl™ vector can be induced prior to DNA p...rovide the stability of single-copy BACs with the ...ng vectors. The kits provide the linearized vector...t size screening system) necessary to create a 10X...
Biology Products: